ID
26407
Description
Study ID: 101468/190 Clinical Study ID: SKF-101468/190 Study Title:A 12 Week, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Efficacy and Safety of Ropinirole in Patients Suffering from Restless Legs Syndrome (RLS). Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Requip Study Indication: Restless Legs Syndrome This is the Form D assessment form.
Keywords
Versions (1)
- 10/17/17 10/17/17 -
Copyright Holder
GlaxoSmithKline
Uploaded on
October 17, 2017
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Form D 26072_GSK Ropinirole in Patients Suffering from Restless Legs Syndrome 101468/190
Form D 26072_GSK Ropinirole in Patients Suffering from Restless Legs Syndrome 101468/190
Similar models
Form D 26072_GSK Ropinirole in Patients Suffering from Restless Legs Syndrome 101468/190
C0243095 (UMLS CUI [1,2])
C0004398 (UMLS CUI [1,3])
C0011900 (UMLS CUI [1,4])
C0011008 (UMLS CUI [1,2])
No comments